(Q44529066)

3 December 2017

title

Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors (English)

1 reference

3 December 2017

0 references

G Martino

1

1 reference

3 December 2017

P L Poliani

2

1 reference

3 December 2017

P C Marconi

3

1 reference

3 December 2017

G Comi

4

1 reference

3 December 2017

R Furlan

5

1 reference

3 December 2017

publication date

1 July 2000

1 reference

3 December 2017

1 reference

3 December 2017

volume

7

1 reference

3 December 2017

issue

13

1 reference

3 December 2017

page(s)

1087-1093

1 reference

A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Immunopathogenesis of multiple sclerosis: the role of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Effector pathways in immune mediated central nervous system demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Exacerbations of multiple sclerosis in patients treated with gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Barrier mechanisms in the brain, I. Adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Gene transfer to brain using herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Rapid method for construction of recombinant HSV gene transfer vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Replication-defective herpes simplex virus vectors for gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

7 January 2021

Cytokine gene expression in cells derived from CSF of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

7 January 2021

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

7 January 2021

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

7 January 2021

Non-coding plasmid DNA induces IFN-gamma in vivo and suppresses autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

7 January 2021

Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301215

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301215

1 reference

3 December 2017

1 reference